Cardiomyopathy Due to Anthracyclines Latest Advances

Therapeutic effect of Fuzheng Yixin decoction on cardiac insufficiencythe soluble guanylyl cyclase-cyclic guanosine monophosphate-protein kinase G pathway in a doxorubicin-induced dilated cardiomyopathy rat model.

Journal: Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan

Published: August 25, 2026

Retraction of The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy.

Journal: The Journal of clinical investigation

Published: August 17, 2026

Longitudinal Change in Cardiac Function After Doxorubicin and Dexrazoxane: A Report From Children's Oncology Group ALTE11C2.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 06, 2026

Meta-Analysis of Genome-Wide Association Studies of Doxorubicin-Induced Arrhythmia Identifies MMP16 and KCTD15 as Risk Loci.

Journal: Circulation. Genomic and precision medicine

Published: July 29, 2026

Third-Space Entrapment of Methotrexate in Anthracycline-Induced Cardiomyopathy: The First Complete Case Trajectory From Toxicity to Rescue Failure.

Journal: Cureus

Published: July 28, 2026

CX3CR1+ macrophages aggravate doxorubicin-induced cardiomyopathy by impairing cardiac mitophagy via the CSF1R-PARP1-IL1B axis.

Journal: Autophagy

Published: July 24, 2026

Cardioprotective effect of natural products on doxorubicin-induced cardiotoxicity and cardiac ischemia-reperfusion injury: A focus on ion channels modulation.

Journal: Current topics in membranes

Published: July 10, 2026

The Quest for a Safer Use of Anthracyclines Continues: Risk Prediction of Clinical Cardiotoxicity.

Journal: JACC. CardioOncology

Published: July 06, 2026

Interplay of oxidative stress and inflammatory mechanisms in doxorubicin-induced cardiomyopathy.

Journal: American journal of physiology. Heart and circulatory physiology

Published: July 02, 2026

Dexrazoxane in children receiving anthracyclines: efficacy, safety, and region-specific considerations for Latin America.

Journal: Cardiology in the young

Published: June 30, 2026

A STING-mediated trialogue: co-ordinating the CD8+ T-cell assault in doxorubicin cardiomyopathy.

Journal: Cardiovascular research

Published: June 26, 2026

Early Detection of Anthracycline-Induced Cardiomyopathy: A Narrative Review of the Role of Artificial Intelligence and Remote Monitoring.

Journal: Cureus

Published: June 23, 2026

Cardiomyopathy Due to Anthracyclines Latest Advances

Find the Latest Research About Cardiomyopathy Due to Anthracyclines

Therapeutic effect of Fuzheng Yixin decoction on cardiac insufficiencythe soluble guanylyl cyclase-cyclic guanosine monophosphate-protein kinase G pathway in a doxorubicin-induced dilated cardiomyopathy rat model.

Therapeutic effect of Fuzheng Yixin decoction on cardiac insufficiencythe soluble guanylyl cyclase-cyclic guanosine monophosphate-protein kinase G pathway in a doxorubicin-induced dilated cardiomyopathy rat model.

Retraction of The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy.

Retraction of The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy.

Longitudinal Change in Cardiac Function After Doxorubicin and Dexrazoxane: A Report From Children's Oncology Group ALTE11C2.

Longitudinal Change in Cardiac Function After Doxorubicin and Dexrazoxane: A Report From Children's Oncology Group ALTE11C2.

Meta-Analysis of Genome-Wide Association Studies of Doxorubicin-Induced Arrhythmia Identifies MMP16 and KCTD15 as Risk Loci.

Meta-Analysis of Genome-Wide Association Studies of Doxorubicin-Induced Arrhythmia Identifies MMP16 and KCTD15 as Risk Loci.

Third-Space Entrapment of Methotrexate in Anthracycline-Induced Cardiomyopathy: The First Complete Case Trajectory From Toxicity to Rescue Failure.

Third-Space Entrapment of Methotrexate in Anthracycline-Induced Cardiomyopathy: The First Complete Case Trajectory From Toxicity to Rescue Failure.

CX3CR1+ macrophages aggravate doxorubicin-induced cardiomyopathy by impairing cardiac mitophagy via the CSF1R-PARP1-IL1B axis.

CX3CR1+ macrophages aggravate doxorubicin-induced cardiomyopathy by impairing cardiac mitophagy via the CSF1R-PARP1-IL1B axis.

Cardioprotective effect of natural products on doxorubicin-induced cardiotoxicity and cardiac ischemia-reperfusion injury: A focus on ion channels modulation.

Cardioprotective effect of natural products on doxorubicin-induced cardiotoxicity and cardiac ischemia-reperfusion injury: A focus on ion channels modulation.

The Quest for a Safer Use of Anthracyclines Continues: Risk Prediction of Clinical Cardiotoxicity.

The Quest for a Safer Use of Anthracyclines Continues: Risk Prediction of Clinical Cardiotoxicity.

Interplay of oxidative stress and inflammatory mechanisms in doxorubicin-induced cardiomyopathy.

Interplay of oxidative stress and inflammatory mechanisms in doxorubicin-induced cardiomyopathy.

Dexrazoxane in children receiving anthracyclines: efficacy, safety, and region-specific considerations for Latin America.

Dexrazoxane in children receiving anthracyclines: efficacy, safety, and region-specific considerations for Latin America.

A STING-mediated trialogue: co-ordinating the CD8+ T-cell assault in doxorubicin cardiomyopathy.

A STING-mediated trialogue: co-ordinating the CD8+ T-cell assault in doxorubicin cardiomyopathy.

Early Detection of Anthracycline-Induced Cardiomyopathy: A Narrative Review of the Role of Artificial Intelligence and Remote Monitoring.

Early Detection of Anthracycline-Induced Cardiomyopathy: A Narrative Review of the Role of Artificial Intelligence and Remote Monitoring.